Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01124188 · ClinicalTrials.gov registry record · Phase 4
ADAPT: Addressing Depression and Pain Together
A Phase 4 study of Depression and Back Pain, sponsored by University of Pittsburgh.
- Completed
- Registry status
- Phase 4
- Development phase
- 263
- Enrollment target
- 1
- Study location
NCT01124188 is a Phase 4 study of Depression and Back Pain that has completed, run by University of Pittsburgh. The registered enrollment target is 263 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01124188, a Phase 4 study of Depression and Back Pain, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 263 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary question addressed by this study is: Using a stepped care approach in primary care, what is the value of the combination of an antidepressant medication (Venlafaxine) and psychotherapy for seniors living with depression and chronic lower back pain when treatment with a low-dose of venlafaxine and supportive management (SM) has led to only a partial or non-response?
Conditions Studied
Interventions
- DRUG Higher-dose venlafaxine
- BEHAVIORAL Supportive management
- BEHAVIORAL Problem Solving Therapy for Depression and Pain
Study Locations (1)
Pennsylvania
- University of Pittsburgh Late Life Depression Program - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 263 participants |
| Start Date | 2010-05 |
| Est. Completion | 2016-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01124188
The ClinicalTrials.gov registry entry for NCT01124188 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 263 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (67% lower). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Depression appearing as the primary indexed condition, and to 3 interventions - of which Higher-dose venlafaxine is the first listed.
NCT01124188 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01124188 about?
NCT01124188 is a clinical study titled "ADAPT: Addressing Depression and Pain Together". The primary question addressed by this study is: Using a stepped care approach in primary care, what is the value of the combination of an antidepressant medication (Venlafaxine) and psychotherapy for seniors living with depression and chronic lower back pain when treatment with a low-dose of venlaf...
What is the current status of trial NCT01124188?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 263 participants. The study started on 2010-05. Estimated completion is 2016-02.
What conditions does trial NCT01124188 study?
This clinical trial studies the following conditions: Depression, Back Pain.
What interventions are being tested in trial NCT01124188?
The interventions under investigation include: Higher-dose venlafaxine (DRUG), Supportive management (BEHAVIORAL), Problem Solving Therapy for Depression and Pain (BEHAVIORAL).
Who is sponsoring clinical trial NCT01124188?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01124188 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Identifying and Treating Depression in the Orthopaedic Trauma Population
RECRUITING · Phase 4
-
Dopaminergic Therapy for Anhedonia - 2
RECRUITING · Phase 4
-
Examining the Effects of Estradiol on Neural and Molecular Response to Reward
RECRUITING · Phase 4
-
Buspirone and Melatonin for Depression Following Traumatic Brain Injury
RECRUITING · Phase 4
-
Processes and Circuitry Underlying Threat Sensitivity as a Treatment Target for Co-morbid Anxiety and Depression
RECRUITING · Phase 4
-
Determining Optimal Treatment Sequences in Anxious Depression (DOTS-AD)
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.